Editorial

Published on 02 Feb 2024

Editorial: Tyrosine kinases and phosphatases in T- cell malignancies

in Hematologic Malignancies

Melania Tesio

Frontiers in Oncology

doi 10.3389/fonc.2024.1372133

729 views

Original Research

Published on 01 Feb 2024

S100A8 is a prognostic signature and associated with immune response in diffuse large B-cell lymphoma

in Hematologic Malignancies

Qi Lin
Jianlin Su
Yuanyuan Fang
Zhihao Zhong
Jie Chen
Chaofeng Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1344669

1,984 views

Case Report

Published on 01 Feb 2024

Case report: Peri-procedural hydroxyurea helps minimize bleeding in patients with Essential Thrombocythemia associated with acquired von Willebrand syndrome

in Hematologic Malignancies

Leah Kogan
Russell Price
Rouslan Kotchetkov

Frontiers in Oncology

doi 10.3389/fonc.2024.1326209

1,468 views

Original Research

Published on 01 Feb 2024

A nationwide analysis of the treatment patterns, survival, and medical costs in Korean patients with relapsed or refractory diffuse large B-cell lymphoma

in Hematologic Malignancies

Jeong-Yeon Cho
Suk-Chan Jang
Dong-Won Kang
Eui-Kyung Lee
Hyein Koh
Dok Hyun Yoon
Mi-Hai Park

Frontiers in Oncology

doi 10.3389/fonc.2024.1282323

2,188 views

Case Report

Published on 31 Jan 2024

Case report: Good response to CMOP regimen containing mitoxantrone hydrochloride liposome (PLM60) as induction chemotherapy in patients with angioimmunoblastic T-cell lymphoma

in Hematologic Malignancies

Lijie Liang
Ming Jiang

Frontiers in Oncology

doi 10.3389/fonc.2024.1331154

1,413 views
1 citation

Original Research

Published on 30 Jan 2024

Risk stratification for early mortality in newly diagnosed acute promyelocytic leukemia: a multicenter, non-selected, retrospective cohort study

in Hematologic Malignancies

Suhyeon Kim
Jiye Jung
Seo-Yeon Ahn
Mihee Kim
So Yeon Jeon
Chang-Hoon Lee
Dae Sik Kim
Se Ryeon Lee
Hwa Jung Sung
Chul Won Choi

Frontiers in Oncology

doi 10.3389/fonc.2024.1307315

1,346 views
1 citation

Case Report

Published on 29 Jan 2024

Allo-HSCT with TBI-based preconditioning for hepatosplenic T-cell lymphoma: two case reports and systematic review of literature

in Hematologic Malignancies

Can Chen
Fan Yang
Peiwen Miu
Pengfei Shi
Shenxian Qian

Frontiers in Oncology

doi 10.3389/fonc.2024.1345464

1,283 views

Case Report

Published on 29 Jan 2024

Case report: Successful treatment of a patient with relapsed/refractory primary central nervous system lymphoma with thiotepa-based induction, autologous stem cell transplantation and maintenance

in Hematologic Malignancies

Luyao Wang
Yili Fan
Boxiao Chen
Jiawei Zhang
Luyu Yang
Xi Qiu
Huawei Jiang
Jinfan Li
Xibin Xiao
Liansheng Huang

Frontiers in Oncology

doi 10.3389/fonc.2023.1333761

1,494 views
1 citation

Review

Published on 29 Jan 2024

Targeting the DNA damage response in hematological malignancies

in Hematologic Malignancies

Sanjay De Mel
Ainsley Ryan Lee
Joelle Hwee Inn Tan
Rachel Zi Yi Tan
Li Mei Poon
Esther Chan
Joanne Lee
Yen Lin Chee
Satish R. Lakshminarasappa
Patrick William Jaynes

Frontiers in Oncology

doi 10.3389/fonc.2024.1307839

1,718 views
2 citations

Systematic Review

Published on 25 Jan 2024

Daratumumab-based immunotherapy vs. lenalidomide, bortezomib and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: a systemic review

in Hematologic Malignancies

Wenjiao Tang
Li Zhang
Yuhuan Zheng
Ling Pan
Ting Niu

Frontiers in Oncology

doi 10.3389/fonc.2024.1286029

2,884 views
1 citation

Case Report

Published on 25 Jan 2024

CPX-351 and allogeneic stem cell transplant for a therapy-related acute myeloid leukemia that developed after treatment of acute promyelocytic leukemia: a case report and review of the literature

in Hematologic Malignancies

Alessandra Sperotto
Maria Teresa Lupo Stanghellini
Jacopo Peccatori
Roberta De Marchi
Simona Piemontese
Giulia Ciotti
Marco Basso
Elisabetta Pierdomenico
Paolo Fiore
Fabio Ciceri

Frontiers in Oncology

doi 10.3389/fonc.2023.1291457

1,600 views

Review

Published on 25 Jan 2024

Advances in the treatment of relapsed/refractory marginal zone lymphoma

in Hematologic Malignancies

Haotian Wang
Xin Wan
Ying Zhang
Jing Guo
Ou Bai

Frontiers in Oncology

doi 10.3389/fonc.2024.1327309

4,889 views

Case Report

Published on 23 Jan 2024

Sequential autologous CAR-T and allogeneic CAR-T therapy successfully treats central nervous system involvement relapsed/refractory ALL: a case report and literature review

in Hematologic Malignancies

Yifan Liu
Yanfen Li
Zhangyu Yu
Rongrong Wang
Yu Jing

Frontiers in Oncology

doi 10.3389/fonc.2024.1341682

2,116 views
1 citation

Review

Published on 23 Jan 2024

Immune checkpoint blockade in hematological malignancies: current state and future potential

in Hematologic Malignancies

Prateek Pophali
Juan Carlos Varela
Jacalyn Rosenblatt

Frontiers in Oncology

doi 10.3389/fonc.2024.1323914

3,585 views
2 citations

Original Research

Published on 23 Jan 2024

Stromal area differences with epithelial-mesenchymal transition gene changes in conjunctival and orbital mucosa-associated lymphoid tissue lymphoma

in Hematologic Malignancies

Mizuki Tagami
Hiroaki Kasashima
Anna Kakehashi
Atsuko Yoshikawa
Mizuho Nishio
Norihiko Misawa
Atsushi Sakai
Hideki Wanibuchi
Masakazu Yashiro
Atsushi Azumi

Frontiers in Oncology

doi 10.3389/fonc.2024.1277749

1,054 views
1 citation

Case Report

Published on 19 Jan 2024

Brentuximab vedotin as a bridge to combination chemotherapy in gray zone lymphoma with severe liver impairment: a case report

in Hematologic Malignancies

Roshan Asrani
Turgot Bora Cengiz
Bruce E. Petersen
Theodora Anagnostou
Joshua D. Brody

Frontiers in Oncology

doi 10.3389/fonc.2023.1254256

1,267 views

Navigation group

Articles

Editorial: Tyrosine kinases and phosphatases in T- cell malignancies

S100A8 is a prognostic signature and associated with immune response in diffuse large B-cell lymphoma

Case report: Peri-procedural hydroxyurea helps minimize bleeding in patients with Essential Thrombocythemia associated with acquired von Willebrand syndrome

A nationwide analysis of the treatment patterns, survival, and medical costs in Korean patients with relapsed or refractory diffuse large B-cell lymphoma

Case report: Good response to CMOP regimen containing mitoxantrone hydrochloride liposome (PLM60) as induction chemotherapy in patients with angioimmunoblastic T-cell lymphoma

Risk stratification for early mortality in newly diagnosed acute promyelocytic leukemia: a multicenter, non-selected, retrospective cohort study

Allo-HSCT with TBI-based preconditioning for hepatosplenic T-cell lymphoma: two case reports and systematic review of literature

Case report: Successful treatment of a patient with relapsed/refractory primary central nervous system lymphoma with thiotepa-based induction, autologous stem cell transplantation and maintenance

Targeting the DNA damage response in hematological malignancies

Daratumumab-based immunotherapy vs. lenalidomide, bortezomib and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: a systemic review

CPX-351 and allogeneic stem cell transplant for a therapy-related acute myeloid leukemia that developed after treatment of acute promyelocytic leukemia: a case report and review of the literature

Advances in the treatment of relapsed/refractory marginal zone lymphoma

Sequential autologous CAR-T and allogeneic CAR-T therapy successfully treats central nervous system involvement relapsed/refractory ALL: a case report and literature review

Immune checkpoint blockade in hematological malignancies: current state and future potential

Stromal area differences with epithelial-mesenchymal transition gene changes in conjunctival and orbital mucosa-associated lymphoid tissue lymphoma

Brentuximab vedotin as a bridge to combination chemotherapy in gray zone lymphoma with severe liver impairment: a case report